Micheal Whelehan

Micheal Whelehan, Ph.D., currently serves as Associate Director of Drug Product Development at Jazz Pharmaceuticals since September 2022. Prior experience includes a role as Senior Manager of New Drug Development at Emergent BioSolutions, focusing on next-generation drugs for opioid use disorders. Micheal's expertise in microencapsulation is demonstrated through positions at Sublimity Therapeutics and Solvotrin Therapeutics, including the co-development of ActiveIron. Additional roles involved process development at Amgen, teaching bio-separations at Dublin City University, and various research positions in microencapsulation and biotechnology. Micheal earned a Bachelor's and a Ph.D. in Biotechnology and Microencapsulation/Bioprocessing from Dublin City University, with a visiting scholarship at EPFL.